Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis
Initial clinical trials and surveillance data have shown that the most commonly administered BNT162b2 COVID-19 mRNA vaccine is effective and safe. However, several cases of mRNA vaccine-induced mild to moderate adverse events were recently reported. Here, we report a rare case of myositis after inje...
שמור ב:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2022-07-01
|
| סדרה: | Vaccines |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2076-393X/10/7/1135 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
